Solid Biosciences Inc.
SLDB· Nasdaq
Released Nov 3, 2021, before the open
10-Q filed Nov 3, 2021, 34 days after period end · 0001564590-21-053726
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 |
| Net Income | -$17.98M | -$21.25M | -$29.26M | -$19.02M |
| EPS Diluted | -$2.40 |
Solid Biosciences Inc. · CIK 1707502 · Engraved from SEC EDGAR
| -$0.44 |
| -$0.67 |
| -$0.55 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.